Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations
- PMID: 16966587
- DOI: 10.1161/CIRCULATIONAHA.105.597013
Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations
Abstract
Background: The purpose of the present study was to evaluate a strategy for safe performance of extrathoracic magnetic resonance imaging (MRI) in non-pacemaker-dependent patients with cardiac pacemakers.
Methods and results: Inclusion criteria were presence of a cardiac pacemaker and urgent clinical need for an MRI examination. Pacemaker-dependent patients and those requiring examinations of the thoracic region were excluded. The study group consisted of 82 pacemaker patients who underwent a total of 115 MRI examinations at 1.5T. To minimize radiofrequency-related lead heating, the specific absorption rate was limited to 1.5 W/kg. All pacemakers were reprogrammed before MRI: If heart rate was <60 bpm, the asynchronous mode was programmed to avoid magnetic resonance (MR)-induced inhibition; if heart rate was >60 bpm, sense-only mode was used to avoid MR-induced competitive pacing and potential proarrhythmia. Patients were monitored with ECG and pulse oximetry. All pacemakers were interrogated immediately before and after the MRI examination and after 3 months, including measurement of pacing capture threshold (PCT) and serum troponin I levels. All MR examinations were completed safely. Inhibition of pacemaker output or induction of arrhythmias was not observed. PCT increased significantly from pre- to post-MRI (P=0.017). In 2 of 195 leads, an increase in PCT was only detected at follow-up. In 4 of 114 examinations, troponin increased from a normal baseline value to above normal after MRI, and in 1 case (troponin pre-MRI 0.02 ng/mL, post-MRI 0.16 ng/mL), this increase was associated with a significant increase in PCT.
Conclusions: Extrathoracic MRI of non-pacemaker-dependent patients can be performed with an acceptable risk-benefit ratio under controlled conditions and by taking both MR- and pacemaker-related precautions.
Comment in
-
Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients.Circulation. 2006 Sep 19;114(12):1232-3. doi: 10.1161/CIRCULATIONAHA.106.647800. Circulation. 2006. PMID: 16982951 No abstract available.
Similar articles
-
Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.J Am Coll Cardiol. 2009 Aug 4;54(6):549-55. doi: 10.1016/j.jacc.2009.04.050. J Am Coll Cardiol. 2009. PMID: 19643318 Clinical Trial.
-
Low-field magnetic resonance imaging: increased safety for pacemaker patients?Europace. 2010 Jul;12(7):952-60. doi: 10.1093/europace/euq081. Epub 2010 Mar 31. Europace. 2010. PMID: 20356915
-
Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla.Pacing Clin Electrophysiol. 2009 Dec;32(12):1526-35. doi: 10.1111/j.1540-8159.2009.02570.x. Epub 2009 Sep 30. Pacing Clin Electrophysiol. 2009. PMID: 19793358
-
Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.Europace. 2008 Mar;10(3):336-46. doi: 10.1093/europace/eun021. Europace. 2008. PMID: 18308754 Review.
-
Magnetic resonance imaging in patients with implantable cardiac devices.Rev Cardiovasc Med. 2008 Fall;9(4):232-8. Rev Cardiovasc Med. 2008. PMID: 19122581 Review.
Cited by
-
MRI-Conditional Cardiac Implantable Electronic Devices: What's New and What Can We Expect in the Future?Curr Treat Options Cardiovasc Med. 2012 Oct;14(5):558-64. doi: 10.1007/s11936-012-0197-2. Curr Treat Options Cardiovasc Med. 2012. PMID: 22851216
-
Institutional experience report on the target contouring workflow in the radiotherapy department for stereotactic arrhythmia radioablation delivered on conventional linear accelerators.Strahlenther Onkol. 2024 Jan;200(1):83-96. doi: 10.1007/s00066-023-02159-6. Epub 2023 Oct 23. Strahlenther Onkol. 2024. PMID: 37872398
-
Can a Simple Flip Make a Difference in MRI Safety in Patients with Cardiac Implantable Electronic Devices?Radiol Cardiothorac Imaging. 2019 Aug 29;1(3):e190151. doi: 10.1148/ryct.2019190151. eCollection 2019 Aug. Radiol Cardiothorac Imaging. 2019. PMID: 33778514 Free PMC article. No abstract available.
-
Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead.J Cardiovasc Magn Reson. 2012 Sep 25;14(1):67. doi: 10.1186/1532-429X-14-67. J Cardiovasc Magn Reson. 2012. PMID: 23009683 Free PMC article.
-
Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators.Korean J Intern Med. 2019 Jan;34(1):99-107. doi: 10.3904/kjim.2017.251. Epub 2018 Apr 4. Korean J Intern Med. 2019. PMID: 29609452 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical